Johnson & Johnson is one of the world's largest and most diversified healthcare giants. Having spun off its consumer health business, the company now focuses exclusively on the R&D and manufacturing of innovative biopharmaceuticals and advanced medical technology. With robust cash flows and consecutive dividend increases, it is a quintessential defensive blue-chip stock in the US market.